This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Iowa Research Foundation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Abhay Divekar: Innovator in Therapeutic Delivery Systems
Introduction
Abhay Divekar is a notable inventor based in Iowa City, IA. He has made significant contributions to the field of therapeutic delivery systems, particularly through his innovative patent. His work focuses on enhancing the delivery of therapeutic compositions to vital organs in mammals.
Latest Patents
Abhay Divekar holds a patent for a method of delivering vectors to the pancreas and lungs by cannulating the aorta. This invention presents a safe and effective way to deliver and express therapeutic compositions, such as transgenes, to the pancreas and lungs of a mammal. This advancement has the potential to improve treatment options for various medical conditions.
Career Highlights
Abhay Divekar is associated with the University of Iowa Research Foundation, where he continues to explore innovative solutions in medical technology. His work is characterized by a commitment to improving health outcomes through scientific research and development.
Collaborations
Abhay has collaborated with esteemed colleagues, including Aliye Uc and Paul B McCray, Jr. These partnerships have fostered a collaborative environment that enhances the research and development of therapeutic delivery methods.
Conclusion
Abhay Divekar's contributions to the field of therapeutic delivery systems exemplify the impact of innovation in medicine. His patent and ongoing research at the University of Iowa Research Foundation highlight the importance of advancing medical technology for better health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile